Pyxis Oncology (PYXS) Total Liabilities (2020 - 2025)

Pyxis Oncology (PYXS) has 6 years of Total Liabilities data on file, last reported at $38.1 million in Q4 2025.

• On a quarterly basis, Total Liabilities rose 4.62% year-over-year to $38.1 million in Q4 2025; TTM through Dec 2025 was $38.1 million, a 4.62% increase from a year earlier, with the FY2025 full-year figure at $38.1 million, up 4.62% from the prior year.
• Total Liabilities for Q4 2025 stood at $38.1 million, up from $36.8 million in the prior quarter.
• Over the last five years, Total Liabilities for PYXS reached as high as $50.6 million in Q4 2022 and fell as low as $16.9 million in Q3 2021.
• Historically, Total Liabilities has averaged $34.7 million across 5 years, with a median of $35.8 million in 2024.
• Across the five-year window, Total Liabilities jumped 385.42% in 2021 and fell 24.14% in 2024, its largest moves.
• Year by year, Total Liabilities stood at $18.7 million in 2021, then surged by 170.23% to $50.6 million in 2022, then declined by 5.01% to $48.0 million in 2023, then fell by 24.14% to $36.4 million in 2024, then advanced by 4.62% to $38.1 million in 2025.
• Per Business Quant data, the three most recent Total Liabilities figures were $38.1 million in Q4 2025, $36.8 million in Q3 2025, and $35.6 million in Q2 2025.